Expert Opinion on Drug Delivery
Volume 18, 2021 - Issue 11
Open access
3,118
Views
4
CrossRef citations to date
0
Altmetric
Technology Evaluation
A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson’s disease
Michael M. Lippa Acorda Therapeutics, Ardsley, NY, USAView further author information
, Anthony J. Hickeyb RTI International, Research Triangle Park, NC, USAView further author information
, Robert Langerc Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USAView further author information
& Peter A. LeWittd Department of Neurology, Henry Ford Hospital and Wayne State University School of Medicine, West Bloomfield, MI, USACorrespondence[email protected]
View further author information
View further author information
Pages 1559-1569
|
Received 19 Apr 2021, Accepted 23 Jul 2021, Published online: 10 Sep 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.